jak1

  1. forestglip

    Favorable responses to upadacitinib, a JAK1 inhibitor, in [LC] with predominant neuropsychiatric symptoms: case reports [...], 2025, Jyonouchi et al

    Favorable responses to upadacitinib, a JAK1 inhibitor, in long COVID patients with predominant neuropsychiatric symptoms: case reports in 2 autistic patients and one typically developing patient Harumi Jyonouchi, Jeffery Kornitzer, Lee Geng [Line breaks added] Abstract The long-term impact of...
    • forestglip
    • Thread
    • autism jak inhibitors jak1 long covid neuropsychiatric disorders upadacitinib
    • Replies: 2
    • Forum: Long Covid research
Back
Top Bottom